000 01440 a2200397 4500
005 20250511223354.0
264 0 _c19901231
008 199012s 0 0 eng d
022 _a0886-4470
024 7 _a10.1001/archotol.1990.01870110043004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRichtsmeier, W J
245 0 0 _aPhase I-II study of advanced head and neck squamous cell carcinoma patients treated with recombinant human interferon gamma.
_h[electronic resource]
260 _bArchives of otolaryngology--head & neck surgery
_cNov 1990
300 _a1271-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aCarcinoma, Squamous Cell
_ximmunology
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aHead and Neck Neoplasms
_ximmunology
650 0 4 _aHumans
650 0 4 _aInterferon-gamma
_xadverse effects
650 0 4 _aKiller Cells, Natural
_xdrug effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Staging
650 0 4 _aRecombinant Proteins
700 1 _aKoch, W M
700 1 _aMcGuire, W P
700 1 _aPoole, M E
700 1 _aChang, E H
773 0 _tArchives of otolaryngology--head & neck surgery
_gvol. 116
_gno. 11
_gp. 1271-7
856 4 0 _uhttps://doi.org/10.1001/archotol.1990.01870110043004
_zAvailable from publisher's website
999 _c2129056
_d2129056